RAD-140 (Testolone)

RAD-140 (Testolone)
RAD-140 (Testolone)
RAD-140 (Testolone)
RAD-140 (Testolone)
RAD-140 (Testolone)
Shortly about Testolone  Effectively increases muscle mass, strength indicators and gives athlete... Read More
  • Stock: Out Of Stock
  • Package: 10mg/tab/50tabs
  • Type: SARM

Shortly about Testolone

  •  Effectively increases muscle mass, strength indicators and gives athletes a relief and powerful appearance and pronounced venousness. Athletes experience greater fullness and stiffness during the intake. 
  •  Suppresses own testosterone significantly compared to lighter compounds such as Ostarine and Andarine
  •  It has a protective effect on the prostate gland, therefore it is useful when used together with anabolic steroids. 
  •  Proven positive effect on breast cancer reduction 

What is Testolone

RAD140 is a new substance that is still being studied in pharmaceutical trials. RAD140 was developed by Radius Pharmaceuticals in the late 2000s as a potential therapeutic agent to prevent muscle wasting in terminally ill patients. It is currently being investigated as a therapeutic agent for breast cancer patients. RAD140 has excellent pharmacokinetic properties and is powerful anabolic. It has similar anabolic effects to LGD4033 and also appears to be a partial agonist in prostate tissue. That is, it can protect the prostate from enlargement when exposed to testosterone or any of its derivatives. Like, S4, it looks like it could be a great addition to any steroid complex to protect against prostate hyperplasia. In addition, RAD140 lowers lipid levels (LDL, HDL, Tryglicerides) without increasing liver enzymes. 


RAD140 is an investigational selective androgen receptor modulator developed by Radius Health Inc for use in androgen replacement therapy. It was licensed by Ellipses Pharmaceuticals in 2020. Some of the potential benefits being investigated are for conditions such as muscle wasting and bone loss. Studies in rats have shown that RAD140 as a drug appears to be safer as a replacement therapy than testosterone. RAD140 also increased lean muscle mass in primates by acting on androgen receptors in skeletal tissue. The first human study was initiated in October 2017 and completed in September 2020 in postmenopausal women with breast cancer. 

PEDs users opinion 

There is a decent amount of unconfirmed information that can be cited due to its popularity in the bodybuilding community. The data itself is rather limited, as only a minority of people regularly record their blood tests and even fewer people get rigorously tested to determine exactly what effect YK11 has had on their bodies. Most YK11 users report impressive increases in muscle growth, st